IR@PKUHSC  > 北京大学临床肿瘤学院  > 肿瘤内科
学科主题临床医学
Clinicopathological and prognostic significance of programmed cell death ligand1 (PD-L1) expression in patients with non-small cell lung cancer: a meta-analysis
Pan, Zhen-Kui1; Ye, Feng2; Wu, Xuan3; An, Han-Xiang2; Wu, Jing-Xun2
关键词Meta-analysis Non-small Cell Lung Cancer (Nsclc) Programmed Cell Death Ligand 1 (Pd-l1) Prognosis
刊名JOURNAL OF THORACIC DISEASE
2015-03-01
DOI10.3978/j.issn.2072-1439.2015.02.13
7期:3页:462-470
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Respiratory System
研究领域[WOS]Respiratory System
关键词[WOS]TUMOR-IMMUNOTHERAPY ; IMMUNE EVASION ; B7-H1 ; BLOCKADE ; ADENOCARCINOMA ; MUTATIONS ; TOLERANCE ; MECHANISM ; ANTIBODY ; SAFETY
英文摘要

Objective: Programmed cell death 1 (PD-1) and one of its ligands, PD-L1, are key immune checkpoint proteins. Evidences showed PD-L1 is an emerging biomarker for immunotherapy by anti-PD-1 and anti-PD-L1 antibody in non-small cell lung cancer (NSCLC). To investigate the association of PD-L1 protein expression with clinicopathological features and its impact on survival outcome, we conducted a meta-analysis.

Methods: A comprehensive literature search of electronic databases (up to July 10, 2014) was performed. Correlation between PD-L1 expression and clinicopathological features and overall survival (OS) was analyzed by synthesizing the qualified data. Publication biases were examined.

Results: A total of 1,550 NSCLC patients from 9 studies were included. The pooled odds ratios (ORs) indicated high PD-L1 expression was associated with poor tumor differentiation [OR = 0.53, 95% confidence interval (CI): 0.39-0.72, P<0.0001]. Whereas, none of other clinicopathological characteristics [gender, smoking status, histological type, invasive depth of tumor, status of lymph node metastasis and tumor node metastasis (TNM) stage] were correlated with PD-L1 expression in current analysis. The combined hazard ratio (HR) for OS showed high expression of PD-L1 impaired the OS in NSCLC (HRpositive/negative = 1.47, 95% CI: 1.19-1.83, P=0.0004).

Conclusions: Our meta-analysis indicated PD-L1 protein expression in NSCLC was not associated with common clinicopathological characteristics, except tumor differentiation. It was a poor prognostic biomarker for NSCLC. Further research should be performed to investigate the precise clinicopathological and prognostic significance of PD-L1 in NSCLC under uniform testing standard.

语种英语
WOS记录号WOS:000353054200053
引用统计
被引频次:55[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/51262
专题北京大学临床肿瘤学院_肿瘤内科
作者单位1.Qingdao Municipal Hosp, Dept Oncol, Qingdao 266011, Peoples R China
2.Xiamen Univ, Affiliated Hosp 1, Dept Med Oncol, Xiamen 361003, Peoples R China
3.Peking Univ Shenzhen Hosp, Dept Med Oncol, Shenzhen 518036, Peoples R China
推荐引用方式
GB/T 7714
Pan, Zhen-Kui,Ye, Feng,Wu, Xuan,et al. Clinicopathological and prognostic significance of programmed cell death ligand1 (PD-L1) expression in patients with non-small cell lung cancer: a meta-analysis[J]. JOURNAL OF THORACIC DISEASE,2015,7(3):462-470.
APA Pan, Zhen-Kui,Ye, Feng,Wu, Xuan,An, Han-Xiang,&Wu, Jing-Xun.(2015).Clinicopathological and prognostic significance of programmed cell death ligand1 (PD-L1) expression in patients with non-small cell lung cancer: a meta-analysis.JOURNAL OF THORACIC DISEASE,7(3),462-470.
MLA Pan, Zhen-Kui,et al."Clinicopathological and prognostic significance of programmed cell death ligand1 (PD-L1) expression in patients with non-small cell lung cancer: a meta-analysis".JOURNAL OF THORACIC DISEASE 7.3(2015):462-470.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Pan, Zhen-Kui]的文章
[Ye, Feng]的文章
[Wu, Xuan]的文章
百度学术
百度学术中相似的文章
[Pan, Zhen-Kui]的文章
[Ye, Feng]的文章
[Wu, Xuan]的文章
必应学术
必应学术中相似的文章
[Pan, Zhen-Kui]的文章
[Ye, Feng]的文章
[Wu, Xuan]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。